title: Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?
abstract: Few reports have suggested that nulliparous young patients with endometrial cancer may be treated conservatively to preserve fertility. We present a young nulliparous woman with a well differentiated adenocarcinoma of the endometrium treated with progestins. Since she did not respond, a definite operation was performed revealing involvement of the uterine isthmus, thus necessitating adjuvant radiotherapy.
authors.affiliation: Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot, Israel. vinker@intemet-zahav.net
authors.forename: S
authors.initials: S
authors.lastname: Vinker
authors.forename: A
authors.initials: A
authors.lastname: Shani
authors.forename: M
authors.initials: M
authors.lastname: Open
authors.forename: E
authors.initials: E
authors.lastname: Fenig
authors.forename: R
authors.initials: R
authors.lastname: Dgani
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D016889:Endometrial Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use*; D009361:Neoplasm Invasiveness; D010052:Ovariectomy; D010298:Parity; D011085:Polycystic Ovary Syndrome / Q000150:complications; D018714:Radiotherapy, Adjuvant
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017258:Medroxyprogesterone Acetate